Clinical Trial: Vasopressin Deficiency in Hemorrhagic Shock

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Vasopressin Deficiency in Hemorrhagic Shock

Brief Summary: In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.

Detailed Summary: This is a prospective observational study. The only research-driven procedure will be the removal of blood samples at designated time points(total blood removed 48 cc per patient). Hemodynamic, fluid infusion and agitation/pain data (RAMSEY Score) will prospectively be collected for research purposes. We will collect data from a convenience sample of patients (when research staff is available) over a one year period.
Sponsor: The University of Texas Health Science Center at San Antonio

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: The University of Texas Health Science Center at San Antonio

Dates:
Date Received: April 19, 2010
Date Started: February 2010
Date Completion:
Last Updated: March 7, 2012
Last Verified: March 2012